Cas9‐orthologue‐mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences
Biotechnology Journal · 2023
DOI: 10.1002/biot.202200533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2023. Verfasst von Min Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Precise Genome Engineering Center, School of Life Sciences, Guangzhou University, Guangzhou, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Excellent Youth Foundation of Guangdong Scientific Committee, National Key Research and Development Program, Shandong Excellent Young Scientists Fund Program.
Abstract (Originalsprache)
CRISPR/Cas9 system has been applied as an effective genome‐targeting technology. By fusing deaminases with Cas9 nickase (nCas9), various cytosine and adenine base editors (CBEs and ABEs) have been successfully developed that can efficiently induce nucleotide conversions and install pathogenic single nucleotide variants (SNVs) in cultured cells and animal models. However, the applications of BEs are frequently limited by the specific protospacer adjacent motif (PAM) sequences and protein sizes. To expand the toolbox for BEs that can recognize novel PAM sequences, we cloned a Cas9 ortholog from Streptococcus sinensis (named as SsiCas9) with a smaller size and constructed it into APOBEC1‐ or APOBEC3A‐composed CBEs and TadA or TadA*‐composed ABEs, which yield high editing efficiencies, low off‐targeting activities, and low indel rates in human cells. Compared to PAMless SpRY Cas9‐composed BE4max, SsiCas9‐mediated BE4max displayed higher editing efficiencies for targets with “NNAAAA” PAM sequences. Moreover, SsiCas9‐mediated BE4max induced highly efficient C‐to‐T conversions in the mouse Ar gene (R841C) to introduce a human androgen resistance syndrome‐related mutation ( AR R820C) in early mouse embryos. Thus, we developed novel BEs mediated by SsiCas9, expanded the toolbox for base conversions, and broadened the range of editable genomes in vitro and in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Precise Genome Engineering Center, School of Life Sciences, Guangzhou University, Guangzhou, China.
- Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Institute of Precision Medicine, Shanghai, China.
- School of Life Sciences, Guangzhou University, Guangzhou, China.
- Department of Endocrinology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
ORCID-Profile: Yunbo Qiao
Förderung
- Excellent Youth Foundation of Guangdong Scientific Committee
- National Key Research and Development Program
- Shandong Excellent Young Scientists Fund Program
- National Key Research and Development Program of China
Zitieren
APA
Li, M., Zhao, Y., Xue, X., Zhong, J., Lin, J., Zhou, J., Yu, W., Chen, J., & Qiao, Y. (2023). Cas9‐orthologue‐mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences. Biotechnology Journal. https://doi.org/10.1002/biot.202200533
Vancouver
Li M, Zhao Y, Xue X, Zhong J, Lin J, Zhou J, et al. Cas9‐orthologue‐mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences. Biotechnology Journal. 2023. doi:10.1002/biot.202200533
BibTeX
@article{Li2023,
author = {Li, Min and Zhao, Yuting and Xue, Xiaowen and Zhong, Jingli and Lin, Jianxiang and Zhou, Jiankui and Yu, Wenhua and Chen, Jun and Qiao, Yunbo},
title = {Cas9‐orthologue‐mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences},
journal = {Biotechnology Journal},
year = {2023},
doi = {10.1002/biot.202200533}
}
EUVIMED